한글목차

세계의 신속 미생물 검사 시장 규모는 예측 기간 중 10.1%의 CAGR로 추이하며, 2024년 52억 달러에서 2029년에는 83억 달러 규모로 성장할 것으로 예측됩니다.

최근 더 새롭고 빠른 기술의 도입으로 전통적인 미생물 검사에서 신속 검사법으로 점차 전환되고 있습니다. 이러한 기술은 박테리아를 생물학적으로 증폭할 필요가 없으므로 보다 빠르고 효율적으로 검출할 수 있습니다. 미생물 검사는 기존 검사 방법의 한계인 긴 소요 시간과 병원성 균주에 대한 노출을 극복하고 있습니다. 유효성, 효율성, 정확성, 결과의 신속성, 기능성을 향상시키기 위한 지속적인 R&D를 통해 미생물 검사의 기술 발전은 임상 실험실, 병원, 학술기관, 연구실, 제약 및 바이오 기술 기업의 관심을 불러일으키고 있습니다.

제품별로는 시약·키트 부문이 예측 기간 중 가장 높은 성장률을 보일 전망입니다. 이 부문의 성장을 촉진하는 주요 요인으로는 감염성 질환 진단 검사 증가, 다양한 시약에 대한 쉬운 접근성, 보다 신뢰할 수 있고 특이적이며 신속한 초기 미생물 검출에 대한 수요 증가 등이 꼽힙니다.

방법론별로는 핵산 기반 부문이 예측 기간 중 가장 높은 성장률을 보일 것으로 예상됩니다. 이 부문의 빠른 성장은 기술 발전, 더 높은 정확도, 맞춤형 기능의 조합에 기인합니다.

지역별로는 아시아태평양이 가장 빠르게 성장하고 있는 지역입니다. 이 지역의 신흥 국가들은 국내총생산(GDP) 증가와 함께 가처분 소득 수준이 눈에 띄게 증가하고 있습니다. 그 결과, 더 많은 사람들이 의료비 지출이 급증하고 있습니다. 이러한 추세는 많은 환자 인구와 이 지역에 많은 저가형 의료기기 제조업체가 존재하기 때문인 것으로 분석됩니다.

세계의 신속 미생물 검사 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회의 분석, 기술·특허의 동향, 법규제 환경, 시장 규모의 추이·예측, 각종 구분·지역별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 중요 인사이트

제5장 시장 개요

• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회
  • 과제
• 가격 분석
• 특허 분석
• 밸류체인 분석
• 공급망 분석
• 무역 분석
• 에코시스템 분석
• Porter's Five Forces 분석
• 규제 상황
• 기술 분석
• 주요 컨퍼런스와 이벤트
• 고객의 비즈니스에 영향을 미치는 동향/디스럽션
• 주요 이해관계자와 구입 기준
• 투자와 자금조달 시나리오

제6장 신속 미생물 검사 시장 : 제품별

• 기기
  • 자동 미생물 식별 및 항균제 감수성 시험 시스템
  • 질량 분석계
  • 생물 발광 및 형광 기반 탐지 시스템
  • PCR 시스템
  • 사이토미터
  • 액티브 에어샘플러
  • 기타
• 시약·키트
  • 멸균 시약·키트
  • 기타 시약·키트
• 소모품

제7장 신속 미생물 검사 시장 : 방법별

• 증식 기반 신속 미생물 검사
• 세포 성분 기반 신속 미생물 검사
• 핵산 기반 신속 미생물 검사
• 생존률 기반 신속 미생물 검사
• 기타

제8장 신속 미생물 검사 시장 : 용도별

• 산업 시험
  • 식품 및 음료 검사
  • 의약품·생물제제 검사
  • 환경 시험
  • 화장품·퍼스널케어 제품 검사
  • 기타
• 임상 질환 진단
• 연구

제9장 신속 미생물 검사 시장 : 지역별

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카
• GCC 국가

제10장 경쟁 구도

• 주요 기업의 채택 어프로치
• 매출 분배 분석
• 시장 점유율 분석
• 기업 평가 매트릭스 : 주요 기업
• 기업 평가 매트릭스 : 스타트업/중소기업
• 신속 미생물 검사 벤더의 평가와 재무 지표
• 브랜드/제품 비교 분석
• 경쟁 시나리오

제11장 기업 개요

• 주요 기업
  • BIOMERIEUX SA
  • BECTON, DICKINSON AND COMPANY
  • DANAHER CORPORATION
  • ABBOTT LABORATORIES
  • THERMO FISHER SCIENTIFIC INC.
  • MERCK KGAA
  • BRUKER
  • QUIDELORTHO CORPORATION
  • SARTORIUS AG
  • CHARLES RIVER LABORATORIES
  • NEOGEN CORPORATION
• 기타 기업
  • DON WHITLEY SCIENTIFIC LIMITED
  • RAPID MICRO BIOSYSTEMS, INC.
  • GRADIENTECH
  • PERKINELMER INC.
  • RQMICRO AG
  • COLIFAST AS
  • SEROSEP LIMITED
  • BTNX INC.
  • R-BIOPHARM AG
  • PARAGON GENOMICS, INC.
  • KYPHA INC.
  • VIVIONE BIOSCIENCES
  • BACTEST LTD.
  • CORDX

제12장 부록

영문목차

The rapid microbiology testing market is valued at an estimated USD 5.2 billion in 2024 and is projected to reach USD 8.3 billion by 2029 at a CAGR of 10.1% during the forecast period. There has been a gradual shift from traditional microbiology testing to rapid testing methods in recent years due to the introduction of newer and faster technologies. These technologies eliminate the need for biological amplification of bacteria, making detection quicker and more efficient. Microbial testing has overcome the limitations of long procedural times and exposure to pathogenic strains associated with conventional testing methods. With continuous developments in efficacy, efficiency, accuracy, faster results, and improved functionality, technological advancements in microbiology testing have generated increased interest among clinical laboratories, hospitals, academic institutes, research laboratories, and pharmaceutical & biotechnology companies.

"Reagents & kits segment accounted for the highest growth rate in the rapid microbiology testing market, by product, during the forecast period."

The rapid microbiology testing market is bifurcated into instruments, reagents & kits, and consumables. The reagents & kits segment in the rapid microbiology testing market is experiencing substantial growth. Major factors driving the growth of this segment include the increasing number of infectious disease diagnostic tests carried out, easy accessibility to a wide range of reagents, and the growing need for more reliable, more specific, and faster detection of microbes in the early stages.

"Nucleic acid-based rapid microbiology testing segment accounted for the highest growth rate in the rapid microbiology testing market, by method, during the forecast period."

The rapid microbiology testing market is bifurcated into growth-based, cellular component-based, nucleic acid-based, viability-based, and other rapid microbiology testing methods based on method. Nucleic acid-based rapid microbiology testing segment is expected to account for the highest CAGR during the forecast period. The rapid growth of this segment is driven by a combination of technological advancements, greater accuracy, and customization capabilities.

"Asia Pacific: The fastest-growing region rapid microbiology testing market."

The worldwide market for rapid microbiology testing is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. Notably, the Asia Pacific region is anticipated to experience the most substantial growth in the forecast period. Emerging economies in this geographical area are observing an upswing in their gross domestic products (GDPs) along with a noteworthy increase in disposable income levels. Consequently, there has been a surge in healthcare expenditure among a larger segment of the population. This trend can be attributed to the sizable patient population and the presence of numerous low-cost device manufacturers in the region.

The break-up of the profile of primary participants in the rapid microbiology testing market:

• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
• By Designation: C-level - 27%, D-level - 18%, and Others - 55%
• By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and Middle East & Africa- 4%

The key players in rapid microbiology testing market are bioMerieux SA (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Sartorius AG (Germany), Bruker (US), QuidelOrtho Corporation (US), Charles River Laboratories (US), Neogen Corporation (US), Don Whitley Scientific Limited (UK), Rapid Micro Biosystems, Inc. (US), Gradientech (Sweden), rqmicro AG (Switzerland), Colifast AS (Norway), Serosep Limited (Ireland), Solus PerkinElmer (US), BTNX Inc. (Canada), R-Biopharm AG (Germany), Paragon Genomics, Inc. (US), Kypha Inc. (US), Vivione Biosciences (US), Bactest Ltd. (UK), and CorDx (US).

Research Coverage:

This research report categorizes the rapid microbiology testing market by product (Instruments (automated microbial identification & antimicrobial susceptibility testing systems, mass spectrometers, PCR systems, bioluminescence & fluorescence-based detection systems, cytometers, active air samplers, other instruments), reagents & kits (sterility testing reagents & kits and other reagents & kits), and consumables), by method (Growth-based rapid microbiology testing, cellular component-based rapid microbiology testing, nucleic acid-based rapid microbiology testing, viability-based rapid microbiology testing, and other rapid microbiology testing methods), by application (Clinical disease diagnosis, industrial testing (food & beverage testing, pharmaceutical & biological drug testing, environmental testing, cosmetics & personal care products testing, and other industrial testing applications), and research applications), and region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the rapid microbiology testing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches and recent developments associated with the rapid microbiology testing market. Competitive analysis of upcoming startups in the rapid microbiology testing market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall rapid microbiology testing market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (Increasing incidence of infectious diseases and cancer, technological advancements in rapid microbiology testing, increased funding for R&D and Increased focus on early detection of infectious diseases), opportunities (Growth opportunities in emerging countries), restraints (High capital investments and low cost-benefit ratio and nfavorable regulatory and reimbursement scenario), and challenges (Operational barriers) influencing the growth of the rapid microbiology testing market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the rapid microbiology testing market.
• Market Development: Comprehensive information about lucrative markets - the report analyses the rapid microbiology testing market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the rapid microbiology testing market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like bioMerieux SA (France), Becton, Dickinson and Company (US), Danaher Corporation (US), Abbott Laboratories (US), and Thermo Fisher Scientific Inc. (US).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 INCLUSIONS & EXCLUSIONS
• 1.4 STUDY SCOPE
  • 1.4.1 RAPID MICROBIOLOGY TESTING MARKET
  • 1.4.2 REGIONS COVERED
  • 1.4.3 YEARS CONSIDERED
  • 1.4.4 CURRENCY CONSIDERED
• 1.5 RESEARCH LIMITATIONS
• 1.6 STAKEHOLDERS
• 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
• 2.2 RESEARCH APPROACH
  • FIGURE 1 RAPID MICROBIOLOGY TESTING MARKET: RESEARCH DESIGN METHODOLOGY
  • 2.2.1 SECONDARY DATA
    • 2.2.1.1 Key data from secondary sources
  • 2.2.2 PRIMARY DATA
    • 2.2.2.1 Primary sources
    • 2.2.2.2 Key data from primary sources
    • 2.2.2.3 Key industry insights
    • 2.2.2.4 Breakdown of primary interviews
  • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• 2.3 MARKET SIZE ESTIMATION
  • 2.3.1 BOTTOM-UP APPROACH
    • 2.3.1.1 Approach 1: Company revenue estimation approach
  • FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
    • 2.3.1.2 Approach 2: Presentations of companies and primary interviews
    • 2.3.1.3 Growth forecast
    • 2.3.1.4 CAGR projections
  • FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • 2.3.2 TOP-DOWN APPROACH
  • FIGURE 6 RAPID MICROBIOLOGY TESTING MARKET: TOP-DOWN APPROACH
• 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
  • FIGURE 7 DATA TRIANGULATION METHODOLOGY
• 2.5 MARKET SHARE
• 2.6 STUDY ASSUMPTIONS
• 2.7 GROWTH RATE ASSUMPTIONS
• 2.8 RISK ASSESSMENT
  • 2.8.1 RISK ASSESSMENT: RAPID MICROBIOLOGY TESTING MARKET
• 2.9 RECESSION IMPACT

3 EXECUTIVE SUMMARY

• FIGURE 8 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
• FIGURE 9 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024 VS. 2029 (USD MILLION)
• FIGURE 10 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
• FIGURE 11 RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)

4 PREMIUM INSIGHTS

• 4.1 RAPID MICROBIOLOGY TESTING MARKET OVERVIEW
  • FIGURE 12 GROWING FOCUS ON EARLY DETECTION OF DISEASES TO SUPPORT MARKET GROWTH DURING FORECAST PERIOD
• 4.2 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 INSTRUMENTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
• 4.3 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 GROWTH-BASED RAPID MICROBIOLOGY TESTING SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
• 4.4 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 INDUSTRIAL TESTING SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
• 4.5 RAPID MICROBIOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 16 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN RAPID MICROBIOLOGY TESTING MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 17 RAPID MICROBIOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing incidence of infectious diseases and cancer
  • TABLE 1 ESTIMATED NUMBER OF NEW CANCER CASES FOR BOTH GENDERS (AGE: 0-85+), 2022 VS. 2045
    • 5.2.1.2 Technological advancements in rapid microbiology testing
    • 5.2.1.3 Increased funding for R&D
    • 5.2.1.4 Increased focus on early detection of infectious diseases
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High capital investments and low cost-benefit ratio
    • 5.2.2.2 Unfavorable regulatory and reimbursement scenario
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growth opportunities in emerging countries
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Operational barriers
• 5.3 PRICING ANALYSIS
  • TABLE 2 INDICATIVE PRICING FOR RAPID MICROBIOLOGY TESTING PRODUCTS
  • TABLE 3 AVERAGE SELLING PRICE OF RAPID MICROBIOLOGY TESTING PRODUCTS, BY REGION
• 5.4 PATENT ANALYSIS
  • FIGURE 18 PATENT ANALYSIS FOR PCR SYSTEMS (JANUARY 2014-DECEMBER 2023)
  • 5.4.1 LIST OF MAJOR PATENTS
• 5.5 VALUE CHAIN ANALYSIS
  • FIGURE 19 VALUE CHAIN ANALYSIS OF RAPID MICROBIOLOGY TESTING MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
• 5.6 SUPPLY CHAIN ANALYSIS
  • FIGURE 20 RAPID MICROBIOLOGY TESTING MARKET: SUPPLY CHAIN ANALYSIS
• 5.7 TRADE ANALYSIS
  • 5.7.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
  • TABLE 4 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 5 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018-2022 (USD MILLION)
• 5.8 ECOSYSTEM ANALYSIS
  • FIGURE 21 RAPID MICROBIOLOGY TESTING MARKET: ECOSYSTEM ANALYSIS
  • 5.8.1 RAPID MICROBIOLOGY TESTING MARKET: ROLE IN ECOSYSTEM
• 5.9 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 6 RAPID MICROBIOLOGY TESTING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.9.1 THREAT OF NEW ENTRANTS
  • 5.9.2 THREAT OF SUBSTITUTES
  • 5.9.3 BARGAINING POWER OF BUYERS
  • 5.9.4 BARGAINING POWER OF SUPPLIERS
  • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.10 REGULATORY LANDSCAPE
  • 5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.10.2 NORTH AMERICA
    • 5.10.2.1 US
    • 5.10.2.2 Canada
  • 5.10.3 EUROPE
  • TABLE 11 EUROPE: CLASSIFICATION OF DEVICES
  • 5.10.4 ASIA PACIFIC
    • 5.10.4.1 China
    • 5.10.4.2 Japan
  • TABLE 12 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
    • 5.10.4.3 India
  • 5.10.5 LATIN AMERICA
    • 5.10.5.1 Brazil
    • 5.10.5.2 Mexico
  • 5.10.6 MIDDLE EAST
    • 5.10.6.1 Africa
• 5.11 TECHNOLOGY ANALYSIS
  • 5.11.1 KEY TECHNOLOGIES
    • 5.11.1.1 Automated multiplex PCR systems
  • 5.11.2 COMPLEMENTARY TECHNOLOGIES
    • 5.11.2.1 Optical immunosensors
    • 5.11.2.2 Electrochemical immunosensors
  • 5.11.3 ADJACENT TECHNOLOGIES
    • 5.11.3.1 MALDI-TOF mass spectrometry
• 5.12 KEY CONFERENCES & EVENTS IN 2024-2025
  • TABLE 13 RAPID MICROBIOLOGY TESTING MARKET: DETAILED LIST OF CONFERENCES & EVENTS
• 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.13.1 REVENUE SHIFT & REVENUE POCKETS FOR RAPID MICROBIOLOGY TESTING MARKET
  • 5.13.2 REVENUE SHIFT IN RAPID MICROBIOLOGY TESTING MARKET
• 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RAPID MICROBIOLOGY TESTING PRODUCTS
  • TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RAPID MICROBIOLOGY TESTING PRODUCTS (%)
  • 5.14.2 BUYING CRITERIA
  • FIGURE 23 KEY BUYING CRITERIA FOR RAPID MICROBIOLOGY TESTING PRODUCTS
  • TABLE 15 KEY BUYING CRITERIA FOR RAPID MICROBIOLOGY TESTING PRODUCTS
• 5.15 INVESTMENT & FUNDING SCENARIO
  • FIGURE 24 RAPID MICROBIOLOGY TESTING MARKET: INVESTMENT & FUNDING SCENARIO

6 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT

• 6.1 INTRODUCTION
  • TABLE 16 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• 6.2 INSTRUMENTS
  • TABLE 17 KEY PRODUCTS IN RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET
  • TABLE 18 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 19 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 20 NORTH AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 21 EUROPE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 22 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 23 LATIN AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.1 AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS
    • 6.2.1.1 Ease of use compared to conventional identification processes to support market growth
  • TABLE 24 RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 25 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 26 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 27 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 28 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.2 MASS SPECTROMETERS
    • 6.2.2.1 Rapid results associated with mass spectrometry methods to boost adoption
  • TABLE 29 RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 30 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 31 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 32 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 33 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.3 BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS
    • 6.2.3.1 Unwanted detection of non-microbial ATP to limit market adoption
  • TABLE 34 RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 35 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 36 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 37 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 38 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.4 PCR SYSTEMS
    • 6.2.4.1 Growing use of standard PCR, real-time PCR, and qPCR for rapid microbial testing to support growth
  • TABLE 39 RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 40 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 41 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 42 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 43 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.5 CYTOMETERS
    • 6.2.5.1 Ability to detect viable organisms to favor market growth
  • TABLE 44 RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 45 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 46 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 47 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 48 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.6 ACTIVE AIR SAMPLERS
    • 6.2.6.1 Convenience and ease of use to drive demand for active air samplers
  • TABLE 49 RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 50 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 51 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 52 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 53 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.7 OTHER INSTRUMENTS
  • TABLE 54 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 55 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 56 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 57 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 58 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
• 6.3 REAGENTS & KITS
  • TABLE 59 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 60 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 61 NORTH AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 62 EUROPE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 64 LATIN AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.1 STERILITY REAGENTS & KITS
    • 6.3.1.1 Increasing adoption of BET assays to propel market growth
  • TABLE 65 RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 66 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 67 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 68 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 69 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.2 OTHER REAGENTS & KITS
  • TABLE 70 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 71 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 72 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 73 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 74 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
• 6.4 CONSUMABLES
  • 6.4.1 DEVELOPMENT OF AUTOMATED ZONE READERS AND DISPENSERS TO DRIVE MARKET GROWTH
  • TABLE 75 RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 76 NORTH AMERICA: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 77 EUROPE: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 79 LATIN AMERICA: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

7 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD

• 7.1 INTRODUCTION
  • TABLE 80 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 81 TYPES OF TECHNOLOGIES USED IN VARIOUS RAPID MICROBIOLOGY TESTING METHODS
• 7.2 GROWTH-BASED RAPID MICROBIOLOGY TESTING
  • 7.2.1 GROWING DEMAND FOR GROWTH-BASED RAPID MICROBIOLOGY TESTING TO DRIVE MARKET GROWTH
  • TABLE 82 GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 83 NORTH AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 84 EUROPE: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 85 ASIA PACIFIC: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 86 LATIN AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• 7.3 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING
  • 7.3.1 HIGH LEVEL OF SENSITIVITY, ACCURACY, AND SPECIFICITY ASSOCIATED WITH THIS METHOD TO BOOST MARKET
  • TABLE 87 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 88 NORTH AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 89 EUROPE: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 90 ASIA PACIFIC: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 91 LATIN AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• 7.4 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING
  • 7.4.1 HIGH ACCURACY ASSOCIATED WITH NUCLEIC ACID-BASED METHODS TO FAVOR MARKET GROWTH
  • TABLE 92 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 93 NORTH AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 94 EUROPE: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 96 LATIN AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• 7.5 VIABILITY-BASED RAPID MICROBIOLOGY TESTING
  • 7.5.1 NEAR REAL-TIME DETECTION AND IMPROVED ACCURACY TO DRIVE DEMAND
  • TABLE 97 VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 98 NORTH AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 99 EUROPE: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 100 ASIA PACIFIC: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 101 LATIN AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• 7.6 OTHER RAPID MICROBIOLOGY TESTING METHODS
  • TABLE 102 OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 103 NORTH AMERICA: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 104 EUROPE: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 105 ASIA PACIFIC: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 106 LATIN AMERICA: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

8 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION

• 8.1 INTRODUCTION
  • TABLE 107 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 8.1.1 PRIMARY NOTES
    • 8.1.1.1 Key industry insights
• 8.2 INDUSTRIAL TESTING
  • TABLE 108 RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 109 RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 110 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 111 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 112 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 113 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.2.1 FOOD & BEVERAGE TESTING
    • 8.2.1.1 Stringent quality control and quality assurance processes to drive market growth
  • TABLE 114 RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 115 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 116 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 117 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 118 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.2.2 PHARMACEUTICAL & BIOLOGICAL DRUG TESTING
    • 8.2.2.1 Improved regulatory scenario for drug development to support market growth
  • TABLE 119 RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 120 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 121 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 122 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 123 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.2.3 ENVIRONMENTAL TESTING
    • 8.2.3.1 Growing focus on environmental monitoring to boost segmental growth
  • TABLE 124 RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 125 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 126 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 127 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 128 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.2.4 COSMETICS & PERSONAL CARE PRODUCTS TESTING
    • 8.2.4.1 Growing use of rapid microbiology testing in these industries to determine presence of microbes to favor market growth
  • TABLE 129 RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 130 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 131 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 133 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.2.5 OTHER INDUSTRIAL TESTING APPLICATIONS
  • TABLE 134 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 135 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 136 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 137 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 138 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• 8.3 CLINICAL DISEASE DIAGNOSIS
  • 8.3.1 HIGH BURDEN OF INFECTIOUS DISEASES AND HAIS TO PROPEL MARKET GROWTH
  • TABLE 139 RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 140 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 141 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 143 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• 8.4 RESEARCH APPLICATIONS
  • 8.4.1 INCREASING NUMBER OF EPIDEMIOLOGY-BASED RESEARCH STUDIES TO DRIVE MARKET GROWTH
  • TABLE 144 RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 145 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 146 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 148 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)

9 RAPID MICROBIOLOGY TESTING MARKET, BY REGION

• 9.1 INTRODUCTION
  • TABLE 149 RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2022-2029 (USD MILLION)
• 9.2 NORTH AMERICA
  • FIGURE 25 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET SNAPSHOT
  • TABLE 150 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 151 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 152 NORTH AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 153 NORTH AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 154 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 155 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.2.1 NORTH AMERICA: RECESSION IMPACT
  • 9.2.2 US
    • 9.2.2.1 Increasing adoption of technologically advanced products in US to favor market growth
  • TABLE 156 US: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 157 US: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 158 US: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 159 US: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 160 US: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.2.3 CANADA
    • 9.2.3.1 Favorable environment for R&D and rising incidence of infectious diseases to drive market
  • TABLE 161 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 162 CANADA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 163 CANADA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 164 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 165 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

• 9.3 EUROPE
  • TABLE 166 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 167 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 168 EUROPE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 169 EUROPE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 170 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 171 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.3.1 EUROPE: RECESSION IMPACT
  • 9.3.2 GERMANY
    • 9.3.2.1 Rising emphasis on food testing and safety to fuel market growth
  • TABLE 172 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 173 GERMANY: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 174 GERMANY: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 175 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 176 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.3.3 UK
    • 9.3.3.1 Increasing investments and funding by government to drive market growth
  • TABLE 177 UK: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 178 UK: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 179 UK: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 180 UK: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 181 UK: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.3.4 FRANCE
    • 9.3.4.1 Rising R&D expenditure to favor market growth
  • TABLE 182 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 183 FRANCE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 184 FRANCE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 185 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 186 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.3.5 ITALY
    • 9.3.5.1 Increased adoption of advanced diagnostic technologies and growing government healthcare investments to drive market
  • TABLE 187 ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 188 ITALY: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 189 ITALY: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 190 ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 191 ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.3.6 SPAIN
    • 9.3.6.1 Rising geriatric population and improving healthcare infrastructure to boost market growth
  • TABLE 192 SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 193 SPAIN: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 194 SPAIN: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 195 SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 196 SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.3.7 RUSSIA
    • 9.3.7.1 Increasing access to quality healthcare to propel market growth
  • TABLE 197 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 198 RUSSIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 199 RUSSIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 200 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 201 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.3.8 REST OF EUROPE
  • TABLE 202 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 203 REST OF EUROPE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 204 REST OF EUROPE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 205 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 206 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• 9.4 ASIA PACIFIC
  • FIGURE 26 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET SNAPSHOT
  • TABLE 207 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 208 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 209 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 210 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 211 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 212 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.4.1 ASIA PACIFIC: RECESSION IMPACT
  • 9.4.2 CHINA
    • 9.4.2.1 Rising importance of quality control across food and pharmaceutical industries to drive market growth
  • TABLE 213 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 214 CHINA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 215 CHINA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 216 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 217 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.4.3 JAPAN
    • 9.4.3.1 Rising geriatric population in Japan to support market growth
  • TABLE 218 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 219 JAPAN: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 220 JAPAN: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 221 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 222 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.4.4 INDIA
    • 9.4.4.1 Increasing private and public investments in healthcare systems to drive adoption of rapid microbiology testing products
  • TABLE 223 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 224 INDIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 225 INDIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 226 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 227 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 Increasing awareness about antimicrobial resistance to fuel market
  • TABLE 228 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 229 AUSTRALIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 230 AUSTRALIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 231 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 232 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.4.6 REST OF ASIA PACIFIC
  • TABLE 233 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 234 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 235 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 236 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 237 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• 9.5 LATIN AMERICA
  • TABLE 238 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 239 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 240 LATIN AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 241 LATIN AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 242 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 243 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.5.1 LATIN AMERICA: RECESSION IMPACT
  • 9.5.2 BRAZIL
    • 9.5.2.1 Improving healthcare infrastructure and stringent regulations to fuel market
  • TABLE 244 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 245 BRAZIL: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 246 BRAZIL: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 247 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 248 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.5.3 MEXICO
    • 9.5.3.1 Improving accessibility and affordability of healthcare services to support market growth
  • TABLE 249 MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 250 MEXICO: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 251 MEXICO: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 252 MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 253 MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.5.4 REST OF LATIN AMERICA
  • TABLE 254 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 255 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 256 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 257 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 258 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 ADVANCEMENTS IN DIAGNOSTIC TECHNOLOGIES AND INCREASED HEALTHCARE INVESTMENTS TO PROPEL MARKET
  • TABLE 259 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 260 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 261 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 262 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 263 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
• 9.7 GCC COUNTRIES
  • 9.7.1 RISING FOCUS ON ADVANCED HEALTH INFRASTRUCTURE TO DRIVE MARKET
  • TABLE 264 GCC COUNTRIES: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 265 GCC COUNTRIES: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 266 GCC COUNTRIES: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 267 GCC COUNTRIES: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022-2029 (USD MILLION)
  • TABLE 268 GCC COUNTRIES: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.7.2 GCC COUNTRIES: RECESSION IMPACT

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
  • 10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN RAPID MICROBIOLOGY TESTING MARKET
  • TABLE 269 RAPID MICROBIOLOGY TESTING MARKET: STRATEGIES ADOPTED
• 10.3 REVENUE SHARE ANALYSIS
  • FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS (2018-2022)
• 10.4 MARKET SHARE ANALYSIS
  • 10.4.1 RAPID MICROBIOLOGY TESTING MARKET
  • FIGURE 28 MARKET SHARE ANALYSIS OF KEY PLAYERS (2022)
  • TABLE 270 RAPID MICROBIOLOGY TESTING MARKET: DEGREE OF COMPETITION
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
  • 10.5.1 LIST OF EVALUATED VENDORS
  • 10.5.2 STARS
  • 10.5.3 EMERGING LEADERS
  • 10.5.4 PERVASIVE PLAYERS
  • 10.5.5 PARTICIPANTS
  • FIGURE 29 RAPID MICROBIOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
  • 10.5.6 COMPANY FOOTPRINT
  • FIGURE 30 RAPID MICROBIOLOGY TESTING MARKET: COMPANY FOOTPRINT
  • TABLE 271 RAPID MICROBIOLOGY TESTING MARKET: PRODUCT FOOTPRINT
  • TABLE 272 RAPID MICROBIOLOGY TESTING MARKET: REGIONAL FOOTPRINT
  • TABLE 273 RAPID MICROBIOLOGY TESTING MARKET: APPLICATION FOOTPRINT
• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • FIGURE 31 RAPID MICROBIOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2022
  • 10.6.5 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
  • TABLE 274 RAPID MICROBIOLOGY TESTING MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
• 10.7 VALUATION AND FINANCIAL METRICS OF RAPID MICROBIOLOGY TESTING VENDORS
  • FIGURE 32 EV/EBITDA OF KEY VENDORS
  • FIGURE 33 P/E RATIO OF KEY VENDORS
• 10.8 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 34 PRODUCT/BRAND COMPARISON: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING PRODUCTS
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 PRODUCT LAUNCHES
  • TABLE 275 RAPID MICROBIOLOGY TESTING MARKET: PRODUCT LAUNCHES, JANUARY 2020-JANUARY 2024
  • 10.9.2 DEALS
  • TABLE 276 RAPID MICROBIOLOGY TESTING MARKET: DEALS, JANUARY 2020-JANUARY 2024
  • 10.9.3 EXPANSIONS
  • TABLE 277 RAPID MICROBIOLOGY TESTING MARKET: EXPANSIONS, JANUARY 2020-JANUARY 2024

11 COMPANY PROFILES

• (Business overview, Products offered, Recent Developments, MNM view)**
• 11.1 KEY PLAYERS
  • 11.1.1 BIOMERIEUX SA
  • TABLE 278 BIOMERIEUX SA: COMPANY OVERVIEW
  • FIGURE 35 BIOMERIEUX SA: COMPANY SNAPSHOT (2022)
  • TABLE 279 BIOMERIEUX SA: PRODUCTS OFFERED
  • TABLE 280 BIOMERIEUX SA: PRODUCT LAUNCHES & APPROVALS
  • TABLE 281 BIOMERIEUX SA: DEALS
  • TABLE 282 BIOMERIEUX SA: OTHER DEVELOPMENTS
  • 11.1.2 BECTON, DICKINSON AND COMPANY
  • TABLE 283 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
  • FIGURE 36 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023)
  • TABLE 284 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
  • TABLE 285 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS
  • TABLE 286 BECTON, DICKINSON AND COMPANY: DEALS
  • 11.1.3 DANAHER CORPORATION
  • TABLE 287 DANAHER CORPORATION: COMPANY OVERVIEW
  • FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
  • TABLE 288 DANAHER CORPORATION: PRODUCTS OFFERED
  • TABLE 289 DANAHER CORPORATION: PRODUCT LAUNCHES & APPROVALS
  • TABLE 290 DANAHER CORPORATION: DEALS
  • TABLE 291 DANAHER CORPORATION: EXPANSIONS
  • 11.1.4 ABBOTT LABORATORIES
  • TABLE 292 ABBOTT LABORATORIES: COMPANY OVERVIEW
  • FIGURE 38 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023)
  • TABLE 293 ABBOTT LABORATORIES: PRODUCTS OFFERED
  • TABLE 294 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS
  • 11.1.5 THERMO FISHER SCIENTIFIC INC.
  • TABLE 295 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • FIGURE 39 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
  • TABLE 296 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 297 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES
  • TABLE 298 THERMO FISHER SCIENTIFIC INC.: DEALS
  • 11.1.6 MERCK KGAA
  • TABLE 299 MERCK KGAA: COMPANY OVERVIEW
  • FIGURE 40 MERCK KGAA: COMPANY SNAPSHOT (2022)
  • TABLE 300 MERCK KGAA: PRODUCTS OFFERED
  • TABLE 301 MERCK KGAA: DEALS
  • 11.1.7 BRUKER
  • TABLE 302 BRUKER: COMPANY OVERVIEW
  • FIGURE 41 BRUKER: COMPANY SNAPSHOT (2022)
  • TABLE 303 BRUKER: PRODUCTS OFFERED
  • TABLE 304 BRUKER: PRODUCT LAUNCHES
  • 11.1.8 QUIDELORTHO CORPORATION
  • TABLE 305 QUIDELORTHO CORPORATION: COMPANY OVERVIEW
  • FIGURE 42 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2022)
  • TABLE 306 QUIDELORTHO CORPORATION: PRODUCTS OFFERED
  • TABLE 307 QUIDELORTHO CORPORATION: PRODUCT LAUNCHES & APPROVALS
  • TABLE 308 QUIDELORTHO CORPORATION: DEALS
  • TABLE 309 QUIDELORTHO CORPORATION: OTHER DEVELOPMENTS
  • 11.1.9 SARTORIUS AG
  • TABLE 310 SARTORIUS AG: COMPANY OVERVIEW
  • FIGURE 43 SARTORIUS AG: COMPANY SNAPSHOT (2023)
  • TABLE 311 SARTORIUS AG: PRODUCTS OFFERED
  • 11.1.10 CHARLES RIVER LABORATORIES
  • TABLE 312 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
  • FIGURE 44 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022)
  • TABLE 313 CHARLES RIVER LABORATORIES: PRODUCTS OFFERED
  • TABLE 314 CHARLES RIVER LABORATORIES: PRODUCT LAUNCHES
  • TABLE 315 CHARLES RIVER LABORATORIES: DEALS
  • 11.1.11 NEOGEN CORPORATION
  • TABLE 316 NEOGEN CORPORATION: COMPANY OVERVIEW
  • FIGURE 45 NEOGEN CORPORATION: COMPANY SNAPSHOT (2022)
  • TABLE 317 NEOGEN CORPORATION: PRODUCTS OFFERED
  • TABLE 318 NEOGEN CORPORATION: PRODUCT LAUNCHES
• *Details on Business overview, Products/Services/Solutions offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
• 11.2 OTHER PLAYERS
  • 11.2.1 DON WHITLEY SCIENTIFIC LIMITED
  • 11.2.2 RAPID MICRO BIOSYSTEMS, INC.
  • 11.2.3 GRADIENTECH
  • 11.2.4 PERKINELMER INC.
  • 11.2.5 RQMICRO AG
  • 11.2.6 COLIFAST AS
  • 11.2.7 SEROSEP LIMITED
  • 11.2.8 BTNX INC.
  • 11.2.9 R-BIOPHARM AG
  • 11.2.10 PARAGON GENOMICS, INC.
  • 11.2.11 KYPHA INC.
  • 11.2.12 VIVIONE BIOSCIENCES
  • 11.2.13 BACTEST LTD.
  • 11.2.14 CORDX

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS